RegenXBio(DE:RB0)
€6.41-0.23 (-3.46%)
DE:RB0
RegenXBio stock drug pipeline
€6.41
At close:-0.23 (-3.46%)
RegenXBio (RB0) Drug Pipeline
1 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does RegenXBio Inc. (DE:RB0) have in its pipeline
RegenXBio DE:RB0 is currently developing the following drugs: Rgx-121-3102, Rgx-202, Rgx-121, Rgx-111. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

